Literature DB >> 16568368

Management of hepatocellular carcinoma in Japan.

Kiwamu Okita1.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16568368     DOI： 10.1007/s00535-005-1763-0

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN： 0944-1174            Impact factor:   7.527


× No keyword cloud information.
  27 in total

1.  Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group.

Authors:  A Kasahara; N Hayashi; K Mochizuki; M Takayanagi; K Yoshioka; S Kakumu; A Iijima; A Urushihara; K Kiyosawa; M Okuda; K Hino; K Okita
Journal:  Hepatology       Date:  1998-05       Impact factor: 17.425

Review 2.  Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score).

Authors:  Masatoshi Kudo; Hobyung Chung; Yukio Osaki
Journal:  J Gastroenterol       Date:  2003       Impact factor: 7.527

3.  Effect of the dose and duration of interferon-alpha therapy on the incidence of hepatocellular carcinoma in noncirrhotic patients with a nonsustained response to interferon for chronic hepatitis C.

Authors:  H Toyoda; T Kumada; S Nakano; I Takeda; K Sugiyama; S Kiriyama; Y Sone; M Tanikawa; Y Hisanaga; K Hayashi; T Honda
Journal:  Oncology       Date:  2001       Impact factor: 2.935

4.  Prognostic factors of hepatocellular carcinoma in the west: a multivariate analysis in 206 patients.

Authors:  X Calvet; J Bruix; P Ginés; C Bru; M Solé; R Vilana; J Rodés
Journal:  Hepatology       Date:  1990-10       Impact factor: 17.425

5.  Report of the 16th follow-up survey of primary liver cancer.

Authors:  Iwao Ikai; Shigeki Arii; Takafumi Ichida; Kiwamu Okita; Masao Omata; Masamichi Kojiro; Kenichi Takayasu; Yasuni Nakanuma; Masatoshi Makuuchi; Yutaka Matsuyama; Yoshio Yamaoka
Journal:  Hepatol Res       Date:  2005-07-18       Impact factor: 4.288

6.  Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm.

Authors:  Shi-Ming Lin; Chun-Jung Lin; Chen-Chun Lin; Chao-Wei Hsu; Yi-Cheng Chen
Journal:  Gastroenterology       Date:  2004-12       Impact factor: 22.682

7.  Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma.

Authors:  T Seki; M Wakabayashi; T Nakagawa; T Itho; T Shiro; K Kunieda; M Sato; S Uchiyama; K Inoue
Journal:  Cancer       Date:  1994-08-01       Impact factor: 6.860

8.  A collaborative study for the evaluation of lectin-reactive alpha-fetoproteins in early detection of hepatocellular carcinoma.

Authors:  K Taketa; Y Endo; C Sekiya; K Tanikawa; T Koji; H Taga; S Satomura; S Matsuura; T Kawai; H Hirai
Journal:  Cancer Res       Date:  1993-11-15       Impact factor: 12.701

9.  Role of vitamin K2 in the development of hepatocellular carcinoma in women with viral cirrhosis of the liver.

Authors:  Daiki Habu; Susumu Shiomi; Akihiro Tamori; Tadashi Takeda; Takashi Tanaka; Shoji Kubo; Shuhei Nishiguchi
Journal:  JAMA       Date:  2004-07-21       Impact factor: 56.272

10.  Role of liver transplantation in cancer therapy.

Authors:  S Iwatsuki; R D Gordon; B W Shaw; T E Starzl
Journal:  Ann Surg       Date:  1985-10       Impact factor: 12.969
View more
  11 in total

1.  CCL5-28, CCL5-403, and CCR5 genetic polymorphisms and their synergic effect with alcohol and tobacco consumptions increase susceptibility to hepatocellular carcinoma.

Authors:  Hsiu-Ting Tsai; Shun-Fa Yang; Dar-Ren Chen; Szu-Erh Chan
Journal:  Med Oncol       Date:  2012-02-29       Impact factor: 3.064

2.  TIMP-3 -1296 T>C and TIMP-4 -55 T>C gene polymorphisms play a role in the susceptibility of hepatocellular carcinoma among women.

Authors:  Hsiu-Ting Tsai; Ming-Ju Hsieh; Hui-Ling Chiou; Hsiang-Lin Lee; Min-Chieh Hsin; Yi-Sheng Liou; Chen-Chieh Yang; Shun-Fa Yang; Wu-Hsien Kuo
Journal:  Tumour Biol       Date:  2014-06-07

3.  Soluble VEGF receptor-2 may be a predictive marker of anti-angiogenic therapy with clinically available safe agents.

Authors:  Hitoshi Yoshiji; Ryuichi Noguchi; Yasuhide Ikenaka; Kosuke Kaji; Yusaku Shirai; Yosuke Aihara; Junichi Yamao; Masahisa Toyohara; Akira Mitoro; Masayoshi Sawai; Motoyuki Yoshida; Chie Morioka; Masao Fujimoto; Masahito Uemura; Hideto Kawaratani; Tatsuhiro Tsujimoto; Hiroshi Fukui
Journal:  Oncol Lett       Date:  2010-10-05       Impact factor: 2.967

4.  A novel technique for the internal drainage of extrahepatic biloma complicating transarterial embolization of hepatocellular carcinoma.

Authors:  Takako Maruyama; Akihiro Mori; Hideharu Tatebe; Katsuhisa Sakai; Naoko Isono; Noritsugu Ohashi; Hiroshi Inoue; Shoudou Takegoshi; Masataka Okuno
Journal:  J Gastroenterol       Date:  2007-09-25       Impact factor: 7.527

Review 5.  Multistep human hepatocarcinogenesis: correlation of imaging with pathology.

Authors:  Masatoshi Kudo
Journal:  J Gastroenterol       Date:  2009-01-16       Impact factor: 7.527

6.  Intraoperative ablation for small HCC not amenable for percutaneous radiofrequency ablation in Child A cirrhotic patients.

Authors:  Ahmed El-Gendi; Mohamed El-Shafei; Fatma Abdel-Aziz; Essam Bedewy
Journal:  J Gastrointest Surg       Date:  2012-11-21       Impact factor: 3.452

7.  Intra-arterial 5-fluorouracil/interferon combination therapy for advanced hepatocellular carcinoma with or without three-dimensional conformal radiotherapy for portal vein tumor thrombosis.

Authors:  Yoshio Katamura; Hiroshi Aikata; Shintaro Takaki; Takahiro Azakami; Tomokazu Kawaoka; Koji Waki; Akira Hiramatsu; Yoshiiku Kawakami; Shoichi Takahashi; Masahiro Kenjo; Naoyuki Toyota; Katsuhide Ito; Kazuaki Chayama
Journal:  J Gastroenterol       Date:  2009-03-28       Impact factor: 7.527

8.  Predictive factor of local recurrence after balloon-occluded TACE with miriplatin (MPT) in hepatocellular carcinoma.

Authors:  Toru Ishikawa; Satoshi Abe; Ryousuke Inoue; Tomoyuki Sugano; Yuhsuke Watanabe; Akito Iwanaga; Keiichi Seki; Terasu Honma; Takeo Nemoto; Keiko Takeda; Toshiaki Yoshida
Journal:  PLoS One       Date:  2014-07-21       Impact factor: 3.240

9.  Consensus on the secondary prevention of primary liver cancer.

Authors:  Yuemin Nan; Xiaoyuan Xu; Yanhang Gao; Rongqi Wang; Wengang Li; Ming Yang; Lingdi Liu; Zhongping Duan; Jidong Jia; Lai Wei; Hui Zhuang
Journal:  Hepatol Int       Date:  2021-11-30       Impact factor: 6.047

10.  The importance of body composition assessment for patients with advanced hepatocellular carcinoma by bioelectrical impedance analysis in lenvatinib treatment.

Authors:  Kenji Yamaoka; Kenichiro Kodama; Tomokazu Kawaoka; Masanari Kosaka; Yusuke Johira; Yuki Shirane; Ryoichi Miura; Shigeki Yano; Serami Murakami; Kei Amioka; Kensuke Naruto; Yuwa Ando; Yumi Kosaka; Shinsuke Uchikawa; Takuro Uchida; Hatsue Fujino; Takashi Nakahara; Eisuke Murakami; Wataru Okamoto; Masami Yamauchi; Daiki Miki; Michio Imamura; Shoichi Takahashi; Akiko Nagao; Kazuaki Chayama; Hiroshi Aikata
Journal:  PLoS One       Date:  2022-01-18       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.